The importance of confirming CFTR mutation genotypes for affected individuals and the significance of this information for extended family members, clinical care and future reproductive decision making

B. Burgess, L. Christie, S. O'Donnell, B. Whitehead, M. Edwards

Research output: Chapter in Book / Conference PaperConference Paperpeer-review

Abstract

We report on 8 years experience working in a multidisciplinary setting with the Paediatric Respiratory Team at John Hunter Children's Hospital to confirm the Cystic Fibrosis Transmembrane Conductance (CFTR) mutations in all affected paediatric patients. This information is essential for cascade testing in the family, reproductive decision making for the proband and relatives and has relevance for clinical care and therapeutic trials. The availability of sequencing of the CFTR gene in the clinical setting has impacted on the genetic services available and the role of the genetic counsellor. The genetic testing service at Hunter Genetics is a specialty area coordinated by a genetic counsellor in an autonomous role.
Original languageEnglish
Title of host publicationAbstracts for the 36th Human Genetics Society of Australasia Annual Scientific Meeting, Canberra, Australia, July 22–25, 2012
PublisherCambridge University Press
Pages590-
Number of pages1
Publication statusPublished - 2012
EventHuman Genetics Society of Australasia. Scientific Meeting -
Duration: 1 Jan 2012 → …

Conference

ConferenceHuman Genetics Society of Australasia. Scientific Meeting
Period1/01/12 → …

Fingerprint

Dive into the research topics of 'The importance of confirming CFTR mutation genotypes for affected individuals and the significance of this information for extended family members, clinical care and future reproductive decision making'. Together they form a unique fingerprint.

Cite this